CAI

Caris Life Sciences, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-03

Figures on this page computed 2026-11-08 02:32 UTC

Last close

25.23USD

Market data, 2026-11-06

CAI: weekly closes from 25.61 on 2025-11-07 to 25.23 on 2026-11-06, a move of -1.5%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-06

Over that span: -1.5%

Except where said otherwise: 10-K for 2025, filed 2026-03-03

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-03
The filing itself
21.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
-8.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
8.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
0.74Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.08 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.12x

0.88x

-0.31x

0.33x

1.01x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-03

Sales2.12x
Its own average over 10 years, 382.4M.
Profit0.88x
Its own average over 10 years, -77.0M.
Free cash flow-0.31x
Its own average over 10 years, -216.5M.
Debt0.33x
Its own average over 9 years, 1.30B.
Price1.01x
Its own average over 2 years, 25. Market data, 2026-11-06

Free cash flow is furthest from its own average, at -0.31 times.

The filed years, as a table

Each line is 100 at 2015-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2015-12-31	100.0	100.0	100.0
2016-12-31	117.9	22.3	92.4
2017-12-31	139.5	268.5	93.4
2018-12-31	173.1	292.9	94.4
2019-12-31	166.8	115.5	85.8
2020-12-31	117.8	103.3	85.5
2022-12-31	103.5	-1,195.4	1,214.0
2023-12-31	122.6	-1,272.1	166.5
2024-12-31	165.1	-1,050.3	169.1
2025-12-31	325.2	-253.7	796.7

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0002019410-26-000016
Reported in: USD

The filing itself

How profit was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0002019410-26-000016
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0002019410-26-000016
Reported in: USD

The filing itself

Figures behind the shape

Growth

22.5%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate22.5%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income75.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

21.6%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital21.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Return on equity-11.8%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
The filing itself
Return on assets-6.0%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
The filing itself

Margins

5.6%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Operating margin5.6%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Net margin-8.4%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Free cash flow margin8.2%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself

Price

12.3x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-03
The filing itself
Price to book12.3x10-Q for 2025, filed 2026-11-04
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0002019410-26-000069
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-11-04
- computed
- 10-K for 2025, filed 2026-03-03
The filing itself
EV to EBITDA99.9x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Price to sales ratio8.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself

Safety

0.74

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.74
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-Q for 2025, filed 2026-11-04
The filing itself
Current ratio7.8510-Q for 2025, filed 2026-11-04
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0002019410-26-000069
Reported in
USD
- 10-Q for 2025, filed 2026-11-04
- 10-Q for 2025, filed 2026-11-04
The filing itself
Interest coverage0.8x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Altman Z-Score6.42
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-03
- Computed from the 10-K for 2025, filed 2026-03-03
- Computed from the 10-K for 2025, filed 2026-03-03
- Computed from the 10-K for 2025, filed 2026-03-03
- Computed from the 10-K for 2025, filed 2026-03-03

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0002019410-26-000016
Reported in
USD
- 10-K for 2025, filed 2026-03-03
- Computed from the 10-K for 2025, filed 2026-03-03
- 10-K for 2025, filed 2026-03-03
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.